Document Type
Presentation
Publication Date
May 2013
Abstract
Cannabis has been implicated as a risk factor for the development of schizophrenia, however, but the pathway of cannabis causing psychosis is not well understood. It appears that cannabis does not cause any structural changes per say but deficits in areas of the brain responsible for memory and emotion do show some changes. Recent studies suggest that cannabinoids such as CB1 have a pharmacological profile similar to that of atypical antipsychotic drugs. This mechanisms may involve dopamine, GABA, and glutamate neurotransmission; It is still not known if these changes are transitory or permanent, and whether or not they contribute to the pathophysiology of schizophrenia. In this presentation we propose a hypothetical model to explain pathways of development of psychosis
Included in
Medical Education Commons, Medical Neurobiology Commons, Neurosciences Commons, Psychiatric and Mental Health Commons